Heparin versus 0.9% sodium chloride intermittent flushing for the prevention of occlusion in long term central venous catheters in infants and children

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 2, 2014, Pages

  Bradford, Natalie K ^a,b   Edwards, Rachel M ^b   Chan, Raymond J ^c,d  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^d QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; SODIUM CHLORIDE;

ARTICLE; CATHETER OCCLUSION; CHEMOPROPHYLAXIS; DRUG EFFECT; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SYSTEMATIC REVIEW;

EID: 85041698608     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD010996     Document Type: Article

References (23)

1. Athale UH, Siciliano S, Cheng J, Thabane L, Chan AK. Central venous line dysfunction is an independent predictor of poor survival in children with cancer. Journal of Pediatric Hematology/Oncology 2012;34(3):188-93.
2. Barclay CA, Vonderhaar KJ, Clark EA. The development of evidence-based care recommendations to improve the safe use of anticoagulants in children. The Journal of Pediatric Pharmacology and Therapeutics 2012;17(2):155-8.
3. Baskin JL, Pui C-H, Reiss U, Wilimas JA, Metzger ML, Ribeiro RC, et al. Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. The Lancet 2009;374(9684):159-69.
4. Bertoglio S, Solari N, Meszaros P, Vassallo F, Bonvento M, Pastorino S, et al. Efficacy of normal saline versus heparinized saline solution for locking catheters of totally implantable long-term central vascular access devices in adult cancer patients. Cancer Nursing 2012;35(4):E35-42.
5. Davis MBH. Pediatric central venous catheter management: a review of current practice. Journal of the Association for Vascular Access 2013;18(2):93-8.
6. Fratino G, Molinari AC, Parodi S, Longo S, Saracco P, Castagnola E, et al. Central venous catheter-related complications in children with oncological/hematological diseases: an observational study of 418 devices. Annals of Oncology 2005;16(4):648-54.
7. Gonzalez G, DavidoffAM, Howard SC, Pui CH, Rao BN, Shenep JL, et al. Safety of central venous catheter placement at diagnosis of acute lymphoblastic leukemia in children. Pediatric Blood & Cancer 2012;58(4):498-502.
8. Goosens GA, Jerome M, Janssens C, Peetermans WE, Fieuws S, Moons P, et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology 2013;24(7):1892-9.
9. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Versions 5.1.0 [updated March 2011] The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
10. Lee OK, Johnston L. A systematic review for effective management of central venous catheters and catheter sites in acute care paediatric patients. Worldviews on Evidence-Based Nursing 2005;2(1):4-13, discussion 14-5.
11. Lopez-Briz E, Ruiz Garcia V, Cabello JB, Bort-Marti S, Carbonell Sanchis R, Burls A. Heparin versus 0.9% sodium chloride intermittent flushing for prevention of occlusion in central venous catheters in adults. Cochrane Database of Systematic Reviews 2010, Issue 4. [DOI: 10.1002/14651858.CD008462]
12. Mitchell MD, Anderson BJ, Williams K, Umscheid CA. Heparin flushing and other interventions to maintain patency of central venous catheters: a systematic review. Journals of Advanced Nursing 2009;65(10):2007-21.
13. Moher D, Liberati A, TezlaffJ, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of Internal Medicine 2009;151(4):264-9.
14. Monagle P, Ignjatovic V, Savoia H. Hemostasis in neonates and children: pitfalls and dilemmas. Blood Reviews 2010;24(2):63-8.
15. Revel-Vilk S, Yacobovich J, Tamary H, Goldstein G, Nemet S, Weintraub M, et al. Risk factors for central venous catheter thrombotic complications in children and adolescents with cancer. Cancer 2010;116(17):4197-205.
16. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
17. Schallom ME, Prentice D, Sona C, Micek S, Skrupky L. Heparin or 9% sodium chloride to maintain central venous catheter patency: a randomized trial. Critical Care Medicine 2012;40(6):1820-6.
18. Schilling S, Doellman D, Hutchinson N, Jacobs BR. The impact of needleless connector device design on central venous catheter occlusion in children: a prospective, controlled trial. JPEN. Journal of Parenteral and Enteral Nutrition 2006;30(2):85-90.
19. Schuster M, Nave H, Piepenbrock S, Pabst R, Panning B. The carina as a landmark in central venous catheter placement. British Journal of Anaesthesia 2000;85(2):192-4.
20. Shah PS, Kalyn A, Satodia P, Dunn MS, Parvez B, Daneman A, et al. A randomized, controlled trial of heparin versus placebo infusion to prolong the usability of peripherally placed percutaneous central venous catheters (PCVCs) in neonates: the HIP (Heparin Infusion for PCVC) study. Pediatrics 2007;119(1):e284-e91.
21. Stocco JGD, Crozeta K, Taminato M, Reichembach-Danski MT, Meier MJ. Evaluation of the mortality of neonates and children related to the use of central venous catheters: a systematic review. Acta Paulista de Enfermagem 2012;25(1):90-5.
22. Wong T, Clifford V, McCallum Z, Shalley H, Peterkin M, Paxton G, et al. Central venous catheter thrombosis associated with 70% ethanol locks in pediatric intestinal failure patients on home parenteral nutrition. A case series. JPEN. Journal of Parenteral and Enteral Nutrition 2012;36(3):358-60.
23. Young G. New anticoagulants in children. ASH Education Program Book 2008;1:245-50.